Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

44.16
+0.48401.11%
Post-market: 44.160.00000.00%16:10 EDT
Volume:15.63K
Turnover:689.44K
Market Cap:213.75M
PE:- -
High:44.79
Open:43.99
Low:43.67
Close:43.68
52wk High:47.00
52wk Low:26.52
Shares:4.84M
Float Shares:4.84M
Volume Ratio:0.71
T/O Rate:0.32%
Dividend:0.02
Dividend Rate:0.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

Legend Biotech (LEGN) Turns Profitable In Q2, Is The Stock Cheap?

Simply Wall St.
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 19

Legend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda

TIPRANKS
·
Aug 19

Eli Lilly EVP, International President Patrik Jonsson Disposes of 6,500 Shares Worth $7.64 Million

Reuters
·
Aug 19

Legend Biotech Seeks Shareholder OK to Add 19.1 Million Shares to RSU Plan Reserve

Reuters
·
Aug 19

Legend Biotech Announces Annual General Meeting

Reuters
·
Aug 19

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send?

TradingKey
·
Aug 19

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value

Simply Wall St.
·
Aug 19

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18

How Legend Biotech’s Q2 Profitability Jump and Interim CEO Shift Will Impact Legend Biotech (LEGN) Investors

Simply Wall St.
·
Aug 18

Swiss Stocks Flat in Early Trading

Dow Jones
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

Eli Lilly Canada: Disagrees with Characterizations in Canada Revenue Agency’s Application; Will Respond Formally Through Court Process in Due Course

THOMSON REUTERS
·
Aug 17

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17